← Back to Search

Speech Production Tasks for Understanding Speech Disorders

N/A

Waitlist Available

Led By Lingyun Zhao, PhD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during inpatient hospitalization, up to 14 days after surgical electrode implantation

Awards & highlights

Study Summary

This trial seeks to understand how the brain controls the stopping of speech production, to help us understand communication disorders like stuttering & aphasia.

Who is the study for?

This trial is for individuals with medication-resistant epilepsy at UCSF who are undergoing surgical electrode implantation to locate their seizure focus. They must be willing and able to cooperate with study tasks involving speech production.Check my eligibility

What is being tested?

The study aims to understand how the brain stops ongoing speech, which is crucial for smooth conversations and turn-taking. It will explore neural mechanisms in patients performing speech tasks during electrode monitoring.See study design

What are the potential side effects?

Since this trial involves non-invasive speech production tasks, there are no direct side effects from interventions like drugs or surgery. However, participants may experience fatigue or stress from the tasks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during inpatient hospitalization, up to 14 days after surgical electrode implantation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during inpatient hospitalization, up to 14 days after surgical electrode implantation

This trial's timeline: 3 weeks for screening, Varies for treatment, and during inpatient hospitalization, up to 14 days after surgical electrode implantation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean Change in Neural Activity

Secondary outcome measures

Number of sites with stimulation induced speech termination

Trial Design

1Treatment groups

Experimental Treatment

Group I: Voice and Electrocorticography (ECoG) recording during Speech Production TasksExperimental Treatment1 Intervention

Participants produce speech following visual cues on a computer while ECoG signals for neural activity and voice was recorded during their inpatient hospitalization at the University of California, San Francisco (UCSF).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,503 Previous Clinical Trials

15,236,625 Total Patients Enrolled

2 Trials studying Speech

112 Patients Enrolled for Speech

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH

328 Previous Clinical Trials

178,275 Total Patients Enrolled

11 Trials studying Speech

1,361 Patients Enrolled for Speech

Lingyun Zhao, PhDPrincipal InvestigatorUniversity of California, San Francisco

Media Library

Voice and Electrocorticography (ECoG) recording during Speech Production Tasks Clinical Trial Eligibility Overview. Trial Name: NCT05876910 — N/A

Speech Research Study Groups: Voice and Electrocorticography (ECoG) recording during Speech Production Tasks

Speech Clinical Trial 2023: Voice and Electrocorticography (ECoG) recording during Speech Production Tasks Highlights & Side Effects. Trial Name: NCT05876910 — N/A

Voice and Electrocorticography (ECoG) recording during Speech Production Tasks 2023 Treatment Timeline for Medical Study. Trial Name: NCT05876910 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I satisfy the criteria necessary to partake in this experiment?

"Eligibility for this clinical trial requires patients to have epilepsy and be between 18-65 years old. Currently, the study is open to approximately 30 members of the cohort."

Answered by AI

Does this clinical trial include participants who are over 20 years of age?

"As per the trial's inclusion criteria, only persons aged between 18 to 65 years are eligible. For those outside of this age range there are 110 trials for minors and 161 for senior citizens."

Answered by AI

Are there any vacancies available for participants in this clinical trial?

"Information available on clinicaltrials.gov declares that this medical trial is not taking new participants, as the study was initially posted in December of 2022 and last updated in May 2023. However, 256 other trials are still actively recruiting patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Neural Mechanisms for Stopping Ongoing Speech Production

2015. "Neural Mechanisms for Stopping Ongoing Speech Production". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05876910.

All > Epilepsy